1.
Beets-Tan RGH,
Lambregts DMJ,
Maas M,
et al.
Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting.
Eur Radiol 2018; 28(4): 1465-75.
2.
Maas M,
Beets-Tan RG,
Lambregts DM,
et al.
Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer.
J Clin Oncol 2011; 29(35): 4633-40.
3.
van der Paardt MP,
Zagers MB,
Beets-Tan RG,
Stoker J,
Bipat S.
Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis.
Radiology 2013; 269(1): 101-12.
4.
Lambregts DM,
van Heeswijk MM,
Delli Pizzi A,
et al.
Diffusion-weighted MRI to assess response to chemoradiotherapy in rectal cancer: main interpretation pitfalls and their use for teaching.
Eur Radiol 2017.
5.
Tamada T,
Kanomata N,
Sone T,
et al.
High b value (2,000 s/mm2) diffusion-weighted magnetic resonance imaging in prostate cancer at 3 Tesla: comparison with 1,000 s/mm2 for tumor conspicuity and discrimination of aggressiveness.
PLoS One 2014; 9(5): e96619.
6.
Fukukura Y,
Kumagae Y,
Hakamada H,
et al.
Computed diffusion-weighted MR imaging for visualization of pancreatic adenocarcinoma: Comparison with acquired diffusion-weighted imaging.
Eur J Radiol 2017; 95: 39-45.
7.
Ueno Y,
Kitajima K,
Sugimura K,
et al.
Ultra-high b-value diffusion-weighted MRI for the detection of prostate cancer with 3-T MRI.
J Magn Reson Imaging 2013; 38(1): 154-60.
8.
Moribata Y,
Kido A,
Fujimoto K,
et al.
Feasibility of Computed Diffusion Weighted Imaging and Optimization of b-value in Cervical Cancer.
Magn Reson Med Sci 2017; 16(1): 66-72.
9.
Hausmann D,
Liu J,
Budjan J,
et al.
Image Quality Assessment of 2D versus 3D T2WI and Evaluation of Ultra-high b-Value (b=2,000 mm/s(2)) DWI for Response Assessment in Rectal Cancer.
Anticancer Res 2018; 38(2): 969-78.
10.
Rosenkrantz AB,
Hindman N,
Lim RP,
et al.
Diffusion-weighted imaging of the prostate: Comparison of b1000 and b2000 image sets for index lesion detection.
J Magn Reson Imaging 2013; 38(3): 694-700.
11.
Ning P,
Shi D,
Sonn GA,
et al.
The impact of computed high b-value images on the diagnostic accuracy of DWI for prostate cancer: A receiver operating characteristics analysis.
Sci Rep 2018; 8(1): 3409.
12.
Goh V,
Halligan S,
Gharpuray A,
Wellsted D,
Sundin J,
Bartram CI.
Quantitative assessment of colorectal cancer tumor vascular parameters by using perfusion CT: influence of tumor region of interest.
Radiology 2008; 247(3): 726-32.
13.
Lambregts DM,
Beets GL,
Maas M,
et al.
Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability.
Eur Radiol 2011; 21(12): 2567-74.
14.
Blazic IM,
Lilic GB,
Gajic MM.
Quantitative Assessment of Rectal Cancer Response to Neoadjuvant Combined Chemotherapy and Radiation Therapy: Comparison of Three Methods of Positioning Region of Interest for ADC Measurements at Diffusion-weighted MR Imaging.
Radiology 2017; 282(2): 615.
15.
Ohgiya Y,
Suyama J,
Seino N,
et al.
Diagnostic accuracy of ultra-high-b-value 3.0-T diffusion-weighted MR imaging for detection of prostate cancer.
Clin Imaging 2012; 36(5): 526-31.
16.
Mazaheri Y,
Hotker AM,
Shukla-Dave A,
Akin O,
Hricak H.
Model selection for high bvalue diffusion-weighted MRI of the prostate.
Magn Reson Imaging 2018; 46: 21-7.
17.
Martens MH,
Maas M,
Heijnen LA,
et al.
Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer.
J Natl Cancer Inst 2016; 108(12).
18.
Lambregts DM,
Lahaye MJ,
Heijnen LA,
et al.
MRI and diffusion-weighted MRI to diagnose a local tumour regrowth during long-term follow-up of rectal cancer patients treated with organ preservation after chemoradiotherapy.
Eur Radiol 2016; 26(7): 2118-25.